Clinical Trials Directory

Trials / Completed

CompletedNCT01631838

Effects of Tocotrienols Supplementation on Platelet Aggregation in Subjects With Metabolic Syndrome

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
32 (actual)
Sponsor
Malaysia Palm Oil Board · Other Government
Sex
All
Age
25 Years – 60 Years
Healthy volunteers
Not accepted

Summary

The objective of this study is to address the anti-thrombotic effects of tocotrienols supplementation via modulation of platelet activation, thrombotic markers, inflammatory markers and endothelial function. It is hypothesized that 2 weeks supplementation of tocotrienols will be able to suppress platelet aggregation in subjects with metabolic syndrome.

Detailed description

A double-blind, randomized, crossover study comparing the effects of tocotrienols vs. placebo will be conducted in subjects with metabolic syndrome. Subjects will be supplemented with Tocovid Suprabio 200 mg twice daily (or placebo) for 2 weeks followed by a postprandial challenge on Day 14. During the postprandial challenge, venous blood samples will be collected during fasting. Subjects are then required to consume a high fat breakfast meal containing 50g fat and 100mL milkshake, followed by the assigned capsules. Venous blood samples will be drawn at 2, 4 and 6 hours after consumption of capsules. A washout period of at least 14 days will be in place before the commencement of the second treatment.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTTocotrienol-rich fraction 400mgTocovid Suprabio 200mg is taken twice daily (after breakfast and dinner) for 2 weeks. During postprandial day (Day 14), subjects are requested to consume breakfast meal containing 50g of fat and 100mL of milkshake, follow by capsule consumption
DIETARY_SUPPLEMENTPlaceboPlacebo is taken twice daily (after breakfast and dinner) for 2 weeks. During postprandial day (Day 14), subjects are requested to consume breakfast meal containing 50g of fat and 100mL of milkshake, follow by capsule consumption

Timeline

Start date
2012-05-01
Primary completion
2012-08-01
Completion
2013-10-01
First posted
2012-06-29
Last updated
2013-12-20

Locations

1 site across 1 country: Malaysia

Source: ClinicalTrials.gov record NCT01631838. Inclusion in this directory is not an endorsement.